There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...
Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect ...
RTX001 has recently entered into a Phase 1/2 interventional study in end-stage liver disease. Edinburgh and London, UK, 11 November 2024 – Resolution Therapeutics Limited (“Resolution” or “Company”), ...
In advanced stages, MASH is associated with severe liver diseases, such as cirrhosis, liver cancer and end-stage liver disease, with high mortality. For Dr. Fatima Bosch, “the gene therapy strategy we ...